Our reported enantioselective construction of the fully
functionalized core motif of (-)-CP-263,114 demonstrates
(13) 2a: Rf ) 0.39 (AcOEt/Hex 3:1); [R]28 +49.0 (c 0.102, CHCl3);
D
1
IR (neat) 3429, 2926, 1699, 1454, 1151, 1111, 1042 cm-1; H NMR (400
MHz, CDCl3) δ 7.38-7.27 (m, 5H), 5.69 (dd, J ) 2.44, 2.20 Hz, 1H),
5.19 (dd, J ) 5.37, 1.95 Hz, 1H), 4.66 (s, 2H), 4.55 (d, J ) 12.5 Hz, 1H),
4.52 (d, J ) 12.2 Hz, 1H), 4.37 (bds, 1H), 4.11 (d, J ) 8.30 Hz, 1H), 3.98
(d, J ) 8.30 Hz, 1H), 3.73 (dq, J ) 9.52, 7.08 Hz, 1H), 3.71 (dd, J ) 9.03,
3.66 Hz, 1H), 3.59-3.53 (m, 3H), 3.45 (dd, J ) 9.03, 6.10 Hz, 1H), 3.44
(dq, J ) 9.52, 7.08 Hz, 1H), 3.35 (s, 3H), 2.86 (d, J ) 11.7 Hz, 1H), 2.82-
2.76 (m, 1H), 2.73 (dd, J ) 11.7, 1.22 Hz, 1H), 2.68 (dd, J ) 11.5, 8.05
Hz, 1H), 2.60-2.58 (m, 1H), 2.40 (dd, J ) 13.2, 5.62 Hz, 1H), 2.12-2.08
(m, 1H), 1.95 (dd, J ) 13.4, 1.95 Hz, 1H), 1.59-1.54 (m, 1H), 1.19 (t, J
) 7.08 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 209.0, 145.6, 138.3, 128.4,
128.2, 127.7, 127.5, 104.4, 96.6, 76.1, 73.2, 72.8, 69.9, 69.4, 63.4, 55.8,
55.1, 51.7, 47.7, 43.0, 42.0, 41.4, 35.2, 15.4; HRMS m/z calcd for C26H36O7
Figure 2. Key NOESY interactions in 31a/31b.
(M+) 460.2462, found 460.2467. 2b: Rf ) 0.36 (AcOEt/hex 3:1); [R]28
D
-81.2 (c 0.079, CHCl3); IR (neat) 3441, 2926, 1699, 1454, 1151, 1113,
1
1042 cm-1; H NMR (400 MHz, CDCl3) δ 7.38-7.27 (m, 5H), 5.71 (dd,
the successful utilization of sequential radical fragmentation-
reductive olefination. The present method provides routes
to both enantiomers of the CP-molecule simply by switching
the chirality of readily available starting material and thus
should constitute an effective means for the asymmetric total
synthesis of natural and unnatural CP-263,114.
J ) 2.93, 1.71 Hz, 1H), 5.26 (dd, J ) 5.37, 4.64 Hz, 1H), 4.66 (s, 2H),
4.53 (s, 2H), 4.38 (bds, 1H), 3.98 (d, J ) 8.30 Hz, 1H), 3.93 (dd, J ) 8.30,
1.00 Hz, 1H), 3.78 (dq, J ) 9.52, 7.08 Hz, 1H), 3.72 (dd, J ) 9.28, 3.90
Hz, 1H), 3.60-3.42 (m, 5H), 3.35 (s, 3H), 2.82-2.74 (m, 1H), 2.77 (d, J )
11.5 Hz, 1H), 2.71 (dd, J ) 11.7, 8.06 Hz, 1H), 2.62-2.56 (m, 1H), 2.34
(dd, J ) 11.5, 1.23 Hz, 1H), 2.27 (ddd, J ) 13.4, 5.62, 1.00 Hz, 1H),
2.14-2.07 (m, 2H), 1.58-1.54 (m, 1H), 1.20 (t, J ) 7.08 Hz, 3H); 13C
NMR (100 MHz, CDCl3) δ 208.9, 144.1, 138.3, 130.2, 128.4, 127.6, 127.5,
104.2, 96.6, 74.9, 73.2, 72.8, 69.6, 69.4, 63.8, 55.9, 55.4, 51.7, 49.5, 43.4,
42.0, 41.9, 35.2, 15.4; HRMS m/z calcd for C26H36O7 (M+) 460.2462, found
Acknowledgment. Financial support from the Japan
Society for the Promotion of Science (Grant-in-Aid for
Encouragement of Young Scientists 12771369) is gratefully
acknowledged.
460.2465. 3a: Rf ) 0.50 (AcOEt/Hex 2:3); [R]28 -11.4 (c 0.333, CHCl3);
D
IR (neat) 2928, 1697, 1107, 1061 cm-1
;
1H NMR (400 MHz, CDCl3) δ
7.39-7.28 (m, 5H), 5.12 (d, J ) 5.86 Hz 1H), 5.00 (d, J ) 12.2 Hz, 1H),
4.62 (d, J ) 12.0 Hz, 1H), 4.55 (s, 2H), 4.49 (d, J ) 12.0 Hz, 1H), 4.03
(dd, J ) 8.06, 1.22 Hz, 1H), 3.97 (dd, J ) 10.0, 2.44 Hz, 1H), 3.93 (d, J
) 8.05 Hz, 1H), 3.75 (dq, J ) 9.52, 7.08 Hz, 1H), 3.68 (dd, J ) 10.0, 1.95
Hz, 1H), 3.61 (d, J ) 2.44 Hz, 1H), 3.55-3.53 (m, 2H), 3.39 (dq, J )
9.52, 7.08 Hz, 1H), 3.30 (s, 3H), 3.23 (dd, J ) 13.4, 0.73 Hz, 1H), 2.94
(dd, J ) 13.4, 6.10 Hz, 1H), 2.78-2.72 (m, 2H), 2.60-2.55 (m, 1H), 2.49
(dd, J ) 14.9, 3.42 Hz, 1H), 2.38-2.31 (m, 1H), 2.10-2.03 (m, 1H), 1.81
(d, J ) 13.4 Hz, 1H), 1.64 (s, 3H), 1.36 (s, 3H), 1.18 (t, J ) 7.08 Hz, 3H);
13C NMR (100 MHz, CDCl3) δ 209.1, 138.2, 128.4, 127.8, 127.7, 108.7,
104.5, 96.7, 82.3, 80.4, 73.6, 71.8, 71.3, 70.8, 63.2, 55.5, 50.8, 50.3, 48.1,
43.4, 42.7, 41.2, 41.1, 29.9, 27.6, 26.3, 15.4; HRMS m/z calcd. for C29H41O8I
OL000290O
2H), 4.49 (d, J ) 12.0 Hz, 1H), 4.08 (dd, J ) 8.05, 1.46 Hz, 1H), 3.96 (dd,
J ) 10.0, 2.44 Hz, 1H), 3.77 (dq, J ) 9.76, 7.08 Hz, 1H), 3.73 (d, J )
2.44 Hz, 1H), 3.69-3.64 (m, 2H), 3.54 (d, J ) 5.61 Hz, 2H), 3.48 (dq, J
) 9.76 7.08 Hz, 1H), 3.30 (s, 3H), 2.77 (dd, J ) 14.7, 8.55 Hz, 1H), 2.68
(dd, J ) 13.7, 5.37 Hz, 1H), 2.64-2.56 (m, 3H), 2.51 (dd, J ) 14.7, 3.66
Hz, 1H), 2.33-2.27 (m, 1H), 2.10-1.98 (m, 2H), 1.62 (s, 3H), 1.34 (s,
3H), 1.22 (t, J ) 7.08 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 208.5,
138.3, 128.4, 127.8, 127.7, 108.7, 104.3, 96.7, 81.4, 79.9, 73.5, 72.1, 71.0,
68.9, 64.0, 55.5, 52.2, 49.7, 48.1, 43.1, 42.9, 41.1, 40.9, 30.3, 27.5, 26.0,
15.4; HRMS m/z calcd for C29H41O8I (M+) 644.1847, found 644.1845.
(M+): 644.1847, found: 644.1858.; 3b: Rf ) 0.40 (AcOEt/Hex 2:3); [R]28
D
-85.7 (c 0.369, CHCl3); IR (neat) 2899, 1693, 1150, 1105, 1055 cm-1; 1H
NMR (400 MHz, CDCl3) δ 7.38-7.28 (m, 5H), 5.15 (dd, J ) 5.61, 5.37
Hz, 1H), 4.89 (d, J ) 12.5 Hz, 1H), 4.63 (d, J ) 12.0 Hz, 1H), 4.55 (s,
3754
Org. Lett., Vol. 2, No. 23, 2000